[1] Arnaiz-Villena A., Benamar D., Alvarez M., Diaz-Campos N, Varela P., Gomez-Casado E., Martinez-Laso J., 1995, “HLA allele and haplotype frequencies in Algerians, relatedness to Spaniards and Basques”, Human Immunology, vol. 43, p. 259-268.
[2] Arnaiz-Villena A., Martinez-Laso J., Gomez-Casado E., Diaz-Campos N., Santos P., Martinho A, Breda-Coimbra H., 1997, “Relatedness among Basques, Portugese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes”, Immunogenetics, vol. 47, p. 37-43.
[3] Ayed K., Bardi R, Gebuhrer L., Betuel H., 1986, “Antigènes HLA-A,-B,-C,-DR dans la population tunisienne”, J. Génét. Hum., vol. 34, N° 2, p. 159.
[4] Ayed K., Bardi R., Gebuhrer L., Gorgi Y., Betuel H., 1987, “HLA-A, -B, -C and DR antigens in a sample of Tunisian population”, Tissue Antigens, vol. 29, N° 225-231.
[5] Ayed K., Bardi R., Gorgi Y., Jennhani F, Chammakhi S. & Boukhris R., 1989, “HLA-A, -B, 6DR antigens and complotype in Tunisian patients with diabetes mellitus”, Dis. Markers ; vol. 7, p. 43-47.
[6] Bardi R., Ju L.-Y, Jenhani S., Ayed K., Chammakhi S. and Charron D., 1991, “Association of type 1 diabetes mellitus with the HLA-DQA1*0301 allele in a Tunisian population”, Res. Immunol, vol. 142, p. 211-216.
[7] Benhamamouch S., Boudjemaa A., Djoulah S., Le Monnier de Gouville I., Kessaoud K., Hors J., Sanchez-Mazas A., 1997, “Anthropological study of west Algerian population”, in Genetic diversity of HLA, Functional and Medical Implication, Ed. D. Charron, EDK, Paris ; vol. 1, p. 181-182.
[8] Benmamar D., Martinez-Laso J., Varela P., Bekhoucha f., Morales P., Arnais-Villena A., 1993, “Evolutionary relationships of HLA-DR8 alleles and description of a new subtype (DRB1*0806) in the Algerian population”, Hum. Immunol, vol. 36, N° 3, p. 172-178.
[9] Betuel H., Camoun M., Colombani J., Day N.-E., Ellouz R. and De The G., 1975, “The relationship between nasopharungeal carcinoma and the HLA system among Tunisians”, Int. J. Cancer, p. 249.
[10] Boetsch G., 1999, Article “Hémotypologie (populations berbères)”, Encyclopédie berbère, t. XXII.
[11] Bone-Tamir B., Bodmer J.-G, Bodmer W.-F., Pickbourne P., Brautbar C., Gazit E, Nevo S., Zamir R., 1978, “HLA polymorphism in Israël. 9. An overall comparative analysis”, Tissue Antigens, vol. 11, p. 235.
[12] Bouali M., Dehay C., Banajam A., Poirier J.-C., Degos L., Marcelli-Barge A.,1981, “HLA-A, B, C, Bf and glyoxalase I polymorphisms in a sample of the Kabylepopulation (Algeria)”, Tissue Antigens, vol. 17, N° 5, p. 501-506.
[13] Bouguerra F., Babron M.-C, Eliaou J.-F., Debbabi A., Clot J., Khaldi F., Greco L., Clerget-Darpoux F., 1997, “Synergestic effet of two HLA heterodimers in the susceptibility to celiac disease in Tunisia”, Genetic epidemiology, vol. 14, p. 413-422.
[14] Colombani J., Degos L., Petrignani C., Chaventre A., Lefevre-Witier P., Jacquard A., 1972, “HLA gene structure of Kel-Kummer Twareg”, in Histocompatibility Testing, 1972, p. 153-162, Munksgaard, Copenhagen.
[15] Dausset J., Colombani J. (Eds), 1973, Histocompatibility Testing – 1972, Munksgaard, Copenhagen.
[16] Degos L., 1982, “Répartition anthropologique des gènes HLA et dynamique des populations”, in : J. Dausset & M. Pla (Eds), Complexe majeur d’histocompatibilité de l’homme, Paris, Flammarion (Coll. Médecine-Science).
[17] Djoulah S., Khalil I., Beresi J.-P., Benhamamouch S., Bessaoud, Deschamps I, Degos L., Hors J., 1992, “HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians”, Eur. J. Immunogenet., vol. 19, p. 54-63.
[18] Djoulah S., Sanchez-Mazas A., Khalil I., Benhamamouch S., Degos L., Deschamps L., Hors J., 1994, “HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations”, Tissue Antigens, vol. 43, N° 2, p. 102-109.
[19] Gonzales-Roces S., Alvarez M.-V., Gonzalez A., Dieye A., Makni H., woodfield D.-G., Housan L., Konenkov V., Abbadi M.-C, Grunnet N., Coto E., Lopez-Larrea C, 1997, “HLA-B27 polymorphism and worldwide susceptibility to Ankylosing spondylitis”, Tissue Antigens, vol. 116-123.
[20] Helal A.-N., Lefranc G, Hauptmann G, Goetz J., Tongio M.-M., Davrinche C., Rivat C., Cavelier B., Chibani J., Chaabani H., 1983, “HLA A*, B*, DF* and C4*A, B* allele associations, with special reference to Bf*SO7, in the Tunisian population” Journal of Immunogenetics, vol. 10, N° 2, p. 205-208.
[21] Herait P., Tarsz T., Guillard M.-Y., Hanna K., Lipinski M., Micheau C., San-cho-Garnier H., Schhab G., Cachin Y., Degos L., De The G., 1983, “HLA A, B and DR antigens in North-African patients with nasopharingeal carcinoma”, Tissue Antigens, vol. 22, p. 335-341.
[22] Hmida S., Gauthier A., Dridi A., Quilivic F., Genet B., Boukef K., Semana G., 1995, “HLA Class II gene polymorphim in Tunisians”, Tissue Antigens, vol. 45, p. 63-68.
[23] Hmida S., Mojaat N., Abid S., Dridi A., Genet B., Boukef K., Semana G., 1995, “Étude du polymorphisme HLA de Classe I dans la population tunisienne”, Transf. Clin. Biol., vol. 2, N° 5, p. 381-386.
[24] Hors J., El Chenawi F., Djoulah S., Hafez M., Abbas F., El Borai M.-H., Kamel M., Abbal M., Cambon-Thomsen A., Mercier P., Reviron D., Magzoub M.-A., Rosner G., Delgado J.-C., Yunis E., Raffoux C., Tamouza R., Izaabel H., Hmida S., Benhamamouch S., Bessaoud K., Langaney A., Sanchez-Mazas A., 1997, “HLA in North African populations : 12th International histocompatibility Workshop NAFR report”, in Genetic diversity of HLA, Functional and Medical Implication, Ed. D. Charron, EDK, Paris, vol. 1, p. 328-334.
[25] Houissa R., Gueguen A., Chadli A., Ben Aissa R., Hors J., Salmon D., 1981, “Les marqueurs HLA dans une population tunisienne”, Rev. Fran. Trans. Immunohémat., vol. 24, N° 2, p. 163-168.
[26] Izaabel H., Garchon H.-J., Beaurin G., Biga M., Akhayat O., Bach J.-F. and Caillat-Zucman S., 1996, “Distribution of HLA Class II alleles and haplotypes in insulin-dependent Moroccan diabetics”, Hum. Immunol., vol. 49, p. 137-143.
[27] Izaabel H., Garchon H.-J., Caillat-Zucman S., Beaurin G., Akhayat O., Bach J.-F., Sanchez-Mazas A., 1998, “HLA Class II DNA polymorphism in a Moroccan population from the Souss, Agadir Area”, Tissue Antigens, vol. 51, p. 106-110.
[28] Jenhani F., Bardi R., Gorgi Y., Ayed K., Chammakhi S., Boukhis R., 1989, “Polymorphisme HLA-A,-B,-C,-DR, C4 et Bf chez les diabétiques insulino-dépendants dans la population tunisienne”, Annales de Biologie Clinique, vol. 47, N° 1, p. 23-28.
[29] Ju L.-Y, Gu X.-F., Bardi R., Krishnamoorthy R., Charron D., 1991, “A simple non-radioactive method of DNA typing for subsets of HLA-DR4 subsets in three diabetic population groups“ Hum. Immunol., vol. 31, p. 251.
[30] Mercier P., Vallo J.-J., Vialettes B., Vague P.-H., 1985, “HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians”, Tissue Antigens, vol. 26, p. 20-24.
[31] Reviron D., Andre M., Cantaloube J.-F., Biagini P., Chicheportiche C., Mercier P., 1993.
“Polymorphism HAL-DRB et DQB1 chez les Algériens originaires d’Alger”, Rev. Franç. Transf. Hémobiol., vol. 36, n° 6, p. 509-516.
[32] Roitberg-Tambur A., Friedmann A., Witt C.-S., Eisenberg S., Soskolne W.-A., Shapira L., Sela M.-N., Battat S., Safirman G., Sherman L., Cohen I., Brautbar C, 1994, “HLA polymorphism in Moroccan jewry”, Hum. Immunol., vol. 40, p. 61-67.
[33] Roitberg-Tambur A., Witt C.-S., Friedmann A., Safirman C., Sherman L., Battat S., Nelken D., Brautbar C., 1995, “Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi jews”, Tissue Antigens, vol. 46, p. 104-110.
[34] Twari J.-L., Terasaki P.-J., 1985, HLA & Disease associations, New York, Spinger-Verlag.